Article
Inactivation of the Lipopeptide Antibiotic Daptomycin by Hydrolytic Mechanisms
15 Nov 2011
Abstract excerpt
The lipopeptide daptomycin is a member of the newest FDA-approved antimicrobial class, exhibiting potency against a broad range of Gram-positive pathogens with only rare incidences of clinical resistance. Environmental bacteria harbor an abundance of resistance determinants orthologous to those in pathogens and thus may serve as an early-warning system for future clinical emergence. A collection of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
